These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8055467)

  • 21. Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Melamed MR; Hutchinson ML; Kaufman EA; Schechter CB; Garner D; Kobler TP; Krieger PA; Reith A; Schenck U
    Acta Cytol; 1998; 42(1):69-75. PubMed ID: 9479325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health care cost containment strategies used in four other high-income countries hold lessons for the United States.
    Stabile M; Thomson S; Allin S; Boyle S; Busse R; Chevreul K; Marchildon G; Mossialos E
    Health Aff (Millwood); 2013 Apr; 32(4):643-52. PubMed ID: 23569043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinician's perspective on laboratory utilization management.
    Yeh DD
    Clin Chim Acta; 2014 Jan; 427():145-50. PubMed ID: 24084504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying costs of medical care. An essential step in allocating resources.
    Conn RB; Aller RD; Lundberg GD
    JAMA; 1985 Mar; 253(11):1586-9. PubMed ID: 3919188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ensuring universal access to quality laboratory services: CLMA White Paper. National Affairs Committee, Clinical Laboratory Management Association.
    Bissell MG
    Clin Lab Manage Rev; 1994; 8(3):185-9, 192-240. PubMed ID: 10171870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulations regarding reflexive testing and narrative interpretations in laboratory medicine.
    MacMillan DH; Soderberg BL; Laposata M
    Am J Clin Pathol; 2001 Dec; 116 Suppl():S129-32. PubMed ID: 11993698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational, cost effective use of investigations. Rising workload and costs in diagnostic departments must be contained.
    Bulusu S
    BMJ; 2002 Jul; 325(7357):222. PubMed ID: 12142322
    [No Abstract]   [Full Text] [Related]  

  • 29. Report on financing the new model of family medicine.
    Spann SJ;
    Ann Fam Med; 2004 Dec; 2 Suppl 3(Suppl 3):S1-21. PubMed ID: 15654084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calculating cost savings in utilization management.
    MacMillan D
    Clin Chim Acta; 2014 Jan; 427():123-6. PubMed ID: 24084505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary care physicians' challenges in ordering clinical laboratory tests and interpreting results.
    Hickner J; Thompson PJ; Wilkinson T; Epner P; Sheehan M; Pollock AM; Lee J; Duke CC; Jackson BR; Taylor JR
    J Am Board Fam Med; 2014; 27(2):268-74. PubMed ID: 24610189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The containment of cost of health care.
    Gordts B
    Acta Chir Belg; 1996 Apr; 96(2):56-8. PubMed ID: 8686402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using an ounce of prevention: does it reduce health care expenditures and reap pounds of profits? A study of the financial impact of wellness and health risk screening programs.
    Phillips JF
    J Health Care Finance; 2009; 36(2):1-12. PubMed ID: 20499716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical laboratory responses to reduced funding.
    Winkelman JW; Hill RB
    JAMA; 1984 Nov; 252(17):2435-40. PubMed ID: 6481930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prudent laboratory usage, cost containment, and high quality medical care: are they compatible?
    Peterson SE; Rodin AE
    Hum Pathol; 1987 Feb; 18(2):105-8. PubMed ID: 3804318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influencing behavior of physicians ordering laboratory tests: a literature study.
    Axt-Adam P; van der Wouden JC; van der Does E
    Med Care; 1993 Sep; 31(9):784-94. PubMed ID: 8366680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of laboratory tests in a teaching hospital: long-term trends: reductions in use and relative cost.
    Griner PF
    Ann Intern Med; 1979 Feb; 90(2):243-8. PubMed ID: 443659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiology and cost control: the ethical challenge for the new millennium.
    Mattke S
    Z Kardiol; 2000 Aug; 89(8):649-57. PubMed ID: 11013969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention in developing countries.
    Black RE
    J Gen Intern Med; 1990; 5(5 Suppl):S132-5. PubMed ID: 2231055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimated costs of 51 commonly ordered laboratory tests in Canada.
    Ma I; Lau CK; Ramdas Z; Jackson R; Naugler C
    Clin Biochem; 2019 Mar; 65():58-60. PubMed ID: 30615855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.